ES2167329T3 - Cristal de hidrato de derivado de acido quinolonacarboxilico. - Google Patents

Cristal de hidrato de derivado de acido quinolonacarboxilico.

Info

Publication number
ES2167329T3
ES2167329T3 ES93902548T ES93902548T ES2167329T3 ES 2167329 T3 ES2167329 T3 ES 2167329T3 ES 93902548 T ES93902548 T ES 93902548T ES 93902548 T ES93902548 T ES 93902548T ES 2167329 T3 ES2167329 T3 ES 2167329T3
Authority
ES
Spain
Prior art keywords
chynolonacarboxylic
acid derivative
crystal
hydration crystal
hydration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93902548T
Other languages
English (en)
Inventor
Hiroyuki Nagano
Nobuyuki Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2167329T3 publication Critical patent/ES2167329T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

DIHIDRATO DEL ACIDO 1 DIHIDRO 8 METOXI OXOQUINOLINA ). EL CRISTAL DEL DIHIDRATO TIENE UNA ESTABILIDAD EXCELENTE EN CONDICIONES DE FABRICACION QUE INCLUYEN ABSORCION DE HUMEDAD Y AMASADURA, COMPARADO CON OTRAS FORMAS DE CRISTAL, SIENDO ASI NOTABLEMENTE ADECUADO PARA LA FABRICACION DE MEDICINAS.
ES93902548T 1992-01-31 1993-01-29 Cristal de hidrato de derivado de acido quinolonacarboxilico. Expired - Lifetime ES2167329T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1654592 1992-01-31

Publications (1)

Publication Number Publication Date
ES2167329T3 true ES2167329T3 (es) 2002-05-16

Family

ID=11919237

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93902548T Expired - Lifetime ES2167329T3 (es) 1992-01-31 1993-01-29 Cristal de hidrato de derivado de acido quinolonacarboxilico.

Country Status (8)

Country Link
US (1) US5597923A (es)
EP (1) EP0629621B1 (es)
KR (1) KR100228572B1 (es)
AT (1) ATE207479T1 (es)
CA (1) CA2128601C (es)
DE (1) DE69331003T2 (es)
ES (1) ES2167329T3 (es)
WO (1) WO1993015070A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0664288A1 (en) * 1992-10-09 1995-07-26 Chugai Seiyaku Kabushiki Kaisha Fluoroquinoline derivative
CZ138297A3 (en) * 1994-11-18 1997-10-15 Pharmacia & Upjohn Novel physically stable form of solid fluoroquinolone
JP3449658B2 (ja) * 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
GB0026490D0 (en) * 2000-10-30 2000-12-13 Pfizer Ltd Process
US7423153B2 (en) 2002-05-10 2008-09-09 Teva Pharmaceutical Industries Ltd. Crystalline forms of gatifloxacin
CA2485262A1 (en) * 2002-05-10 2003-11-20 Teva Pharmaceutical Industries Ltd Novel crystalline forms of gatifloxacin
EP1645274A1 (en) * 2002-05-10 2006-04-12 Teva Pharmaceutical Industries Ltd. Process for making gatifloxacin form omega
WO2003105851A1 (en) 2002-06-01 2003-12-24 Teva Pharmaceuticals Industries Ltd. Novel crystalline forms of gatifloxacin
JP2006508909A (ja) * 2002-08-06 2006-03-16 テバ ファーマシューティカル インダストリーズ リミティド ガチフロキサシンの新規な結晶形
WO2005012285A1 (en) * 2003-08-05 2005-02-10 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
US7781585B2 (en) 2004-06-04 2010-08-24 Matrix Laboratories Ltd Crystalline forms of Gatifloxacin
US7594151B2 (en) * 2004-06-18 2009-09-22 Qualcomm, Incorporated Reverse link power control in an orthogonal system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JPS63198664A (ja) * 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
JPS6490184A (en) * 1987-09-30 1989-04-06 Sankyo Co Pyridonecarboxylic acids
DE68920773T2 (de) * 1988-05-19 1995-05-18 Chugai Pharmaceutical Co Ltd Chinoloncarbonsäure-Derivate.

Also Published As

Publication number Publication date
DE69331003D1 (de) 2001-11-29
US5597923A (en) 1997-01-28
EP0629621A1 (en) 1994-12-21
DE69331003T2 (de) 2002-06-20
WO1993015070A1 (en) 1993-08-05
CA2128601C (en) 2003-07-15
KR950700281A (ko) 1995-01-16
EP0629621A4 (en) 1995-02-01
EP0629621B1 (en) 2001-10-24
CA2128601A1 (en) 1993-08-05
KR100228572B1 (ko) 1999-11-01
ATE207479T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
ES2167329T3 (es) Cristal de hidrato de derivado de acido quinolonacarboxilico.
PT87381A (pt) Process for the manufacture of oral forms of administration with delayed release containing carbamazepine
ES2052829T3 (es) Aminoetiltetralinas substituidas asi como sus analogos heterociclicos.
IT1200092B (it) Derivati amminopropossi, loro preparazione e loro impiego come medicamenti
IT1016726B (it) Procedimento per la riduzione del tenore di vapori nitrosi negli af fluenti gassosi nitrosi
ES2046176T3 (es) Composicion farmaceutica que contiene una asociacion de colageno y de un principio activo antiseptico y/o antiinflamatorio y su procedimiento de fabricacion.
MX9308013A (es) 4-fenil-piridonas y 4-fenil-2-fenil-2-alcoxipiridinas sustituidas, procedimiento para su preparacion y medicamentos que los contienen.
AR002953A1 (es) Purin-6-onas bisustituidas en 2,9, procedimiento para su produccion, medicamentos que las contienen y el uso de dichos compuestos para prepararmedicamentos.
IT8322565A0 (it) Derivati della desossiuridina, loro preparazione e loro impiego come medicamenti.
IT8948682A0 (it) Derivati della capsaicina, loro preparazione e loro impiego come medicamenti (caso 700-0062)
NL7701740A (nl) Hoge druk ontladingslichtbron met metaalhalogenide toevoeging.
AR012946A1 (es) Forma cristalina a de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida, preparaciones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
BR8100484A (pt) Compostos, compostos intermediarios para os mesmos, processo para fabricacao dos compostos inicialmente mencionados, medicamento, agente analgesico, e uso dos compostos inicialmente mencionados
FR2442828A1 (fr) Procede de fabrication de nitroparaffines par nitration de l'ethane en phase gazeuse
ES2166800T3 (es) Procedimiento para la preparacion de o,s-acetales de 2,2-difluoroceteno sililo y o,s-esteres del acido alfa,alfa-difluoro-beta-sililoxi-1,3-dioxolan-4-propanoico.
ES2063484T3 (es) Conjunto de perfiles para la fabricacion de paredes continuas de cristal para edificios.
IT8009577A0 (it) Derivati 1-oxadetiacefalosporina, loro produzione,e loro impiego come antibatterici
MX9206612A (es) Amidas del acido quinolilmetoxifenilacetico, procedimiento para su fabricacion y medicamento que las contiene
MX9301237A (es) Nuevos derivados del acido aminocarboxililco con efecto antialergico antiasmatico y procedimiento para su elaboracion.
IT1122181B (it) Antibiotici,procedimento per la loro preparazione,e coltura biologicamente pura per impiego in tale procedimento
IT1199203B (it) Derivati del carbapenem fluoroalchilati,loro preparazione e loro impiego come medicamenti
MX9206365A (es) Tetrahidrobenzotienopiridinas,proceso para su preparacion y composicion farmaceutica que las contiene
IT1212552B (it) Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica
SE8802040D0 (sv) New use
IT1189293B (it) Derivati della 4-ammino-benzilammina,loro preparazione e loro impiego come medicamenti